Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Sep 30, 2020 | Option Exercise | $0.53 | 366 | 195 | 185,393 | Oct 01, 2020, 04:30 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Aug 31, 2020 | Option Exercise | $0.62 | 366 | 227 | 185,759 | Sep 02, 2020, 05:15 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Aug 20, 2020 | Option Exercise | $0.65 | 3,759 | 2,434 | 186,125 | Aug 21, 2020, 07:03 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Jul 31, 2020 | Option Exercise | $0.76 | 366 | 278 | 178,634 | Aug 04, 2020, 04:09 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Jun 30, 2020 | Option Exercise | $0.67 | 366 | 247 | 179,000 | Jul 02, 2020, 04:07 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | May 31, 2020 | Option Exercise | $1.14 | 366 | 417 | 179,366 | Jun 03, 2020, 06:06 AM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Apr 30, 2020 | Option Exercise | $0.55 | 366 | 201 | 179,732 | May 04, 2020, 06:30 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Mar 31, 2020 | Option Exercise | $0.57 | 366 | 210 | 180,098 | Apr 02, 2020, 05:49 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Feb 28, 2020 | Option Exercise | $1.35 | 366 | 494 | 180,464 | Mar 03, 2020, 09:31 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Jan 31, 2020 | Option Exercise | $1.35 | 3,892 | 5,254 | 75,830 | Feb 04, 2020, 08:55 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Aug 22, 2019 | Buy | $2.04 | 4,800 | 9,780 | 15,972 | Aug 26, 2019, 09:49 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Aug 21, 2019 | Sale | $2.08 | 3,797 | 7,898 | 11,172 | Aug 26, 2019, 09:34 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Aug 21, 2019 | Option Exercise | $2.08 | 3,797 | 7,898 | 11,172 | Aug 21, 2019, 09:21 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | May 23, 2018 | Buy | $4.60 | 2,160 | 9,936 | 3,719 | May 29, 2018, 01:48 PM | |
NBRV | Nabriva Therapeutics plc | Lavino Francesco Maria | Chief Commercial Officer | Nov 29, 2017 | Buy | $6.29 | 1,569 | 9,869 | 1,569 | Dec 01, 2017, 04:07 PM |